Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development

Author:

Graepel Kevin W1ORCID,Kochhar Sonali23,Clayton Ellen W456,Edwards Kathryn E7

Affiliation:

1. Vanderbilt University School of Medicine, Nashville, Tennessee, USA

2. Global Healthcare Consulting, New Delhi, India

3. Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, Washington, USA

4. Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA

5. Center for Biomedical Ethics and Society and Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee, USA

6. Vanderbilt University Law School, Nashville, Tennessee, USA

7. Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference21 articles.

1. The COVID-19 vaccine development landscape [manuscript published online ahead of print 9 April 2020];Le;Nat Rev Drug Discov,2020

2. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications;Wu;medRxiv [Preprint],2020

3. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques;Bao;bioRxiv,2020

4. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial;Modjarrad;Lancet Infect Dis,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3